A099

Bio Plus Co., Ltd Stock Price

KOSDAQ:A099430 Community·₩393.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

A099430 Share Price Performance

₩6,680.00
1570.00 (30.72%)
₩6,680.00
1570.00 (30.72%)
Price ₩6,680.00

A099430 Community Narratives

There are no narratives available yet.

Recent A099430 News & Updates

Bio Plus (KOSDAQ:099430) Seems To Use Debt Quite Sensibly

Aug 18
Bio Plus (KOSDAQ:099430) Seems To Use Debt Quite Sensibly

Capital Allocation Trends At Bio Plus (KOSDAQ:099430) Aren't Ideal

Jul 22
Capital Allocation Trends At Bio Plus (KOSDAQ:099430) Aren't Ideal

What Bio Plus Co., Ltd's (KOSDAQ:099430) 26% Share Price Gain Is Not Telling You

May 09
What Bio Plus Co., Ltd's (KOSDAQ:099430) 26% Share Price Gain Is Not Telling You

Bio Plus' (KOSDAQ:099430) Anemic Earnings Might Be Worse Than You Think

Mar 31
Bio Plus' (KOSDAQ:099430) Anemic Earnings Might Be Worse Than You Think

Does Bio Plus (KOSDAQ:099430) Have A Healthy Balance Sheet?

Feb 14
Does Bio Plus (KOSDAQ:099430) Have A Healthy Balance Sheet?

Bio Plus Co., Ltd's (KOSDAQ:099430) Shares Climb 30% But Its Business Is Yet to Catch Up

Jan 07
Bio Plus Co., Ltd's (KOSDAQ:099430) Shares Climb 30% But Its Business Is Yet to Catch Up

Bio Plus (KOSDAQ:099430) Is Reinvesting At Lower Rates Of Return

Dec 15
Bio Plus (KOSDAQ:099430) Is Reinvesting At Lower Rates Of Return

Bio Plus Co., Ltd Key Details

₩89.2b

Revenue

₩30.2b

Cost of Revenue

₩59.0b

Gross Profit

₩42.8b

Other Expenses

₩16.2b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
275.15
Gross Margin
66.15%
Net Profit Margin
18.18%
Debt/Equity Ratio
33.2%

Bio Plus Co., Ltd Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Adequate balance sheet with very low risk.

2 Risks
0 Rewards

About A099430

Founded
2003
Employees
125
CEO
Hyun-Kyu Jung
WebsiteView website
www.bioplus.co.kr

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; Slim Slimmer, a lipolysis solution; LumiDew, a whitening solution; JuveniHill, an anti-wrinkle solution; and hair scalp care, hair treatment, hair nutrition solutions under the BelloHa and BellaChe names, as well as cosmetics comprising heparinoid essence, EGF ball, and skin care gel under the La Bella name. The company was founded in 2003 and is based in Seongnam-si, South Korea.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

South Korean Market Performance

  • 7 Days: 2.5%
  • 3 Months: 11.5%
  • 1 Year: 33.0%
  • Year to Date: 44.6%
The market has climbed 2.5% in the last 7 days, lead by the Information Technology sector with a gain of 4.7%. In the last year, the market has climbed 33%. As for the next few years, earnings are expected to grow by 24% per annum. Market details ›